Mark Prygocki
Vermögen: - $ am 31.07.2026
Vermögen: - $ am 31.07.2026
Mark A. Prygocki is currently Director at Visions of Hope, Inc., Independent Director at Verrica Pharmaceuticals, Inc. since 2018, and a Member of both The Financial Executives Institute and the New York State Society of Certified Public Accountants.
Former roles include President, Chief Executive Officer & Director at Illustris Pharmaceuticals, Inc. from 2017 to 2020; Independent Director at Revance Therapeutics, Inc. from 2014 to 2017; Director at The Whispering Hope Ranch Foundation; Independent Director at Clarus Therapeutics Holdings, Inc. from 2021 to 2022; Executive Director at Clarus Therapeutics, Inc. from 2014 to 2022; President at Medicis Pharmaceutical Corp.
from 2010 to 2012; and Principal at Ernst & Young LLP.
Education includes undergraduate studies at Pace University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.06.2026 | 0 ( -.--% ) | - $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| VERRICA PHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | 01.05.2018 |
The Financial Executives Institute | Corporate Officer/Principal | - |
Visions of Hope, Inc. | Direktor/Vorstandsmitglied | - |
New York State Society of Certified Public Accountants
New York State Society of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Operates certified public accountant membership association | Corporate Officer/Principal | 14.04.2010 |
| Unternehmen | Position | Ende |
|---|---|---|
Clarus Therapeutics, Inc.
Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for men hypogonadism | Direktor/Vorstandsmitglied | 01.12.2022 |
| CLARUS THERAPEUTICS HOLDINGS, INC. | Direktor/Vorstandsmitglied | 31.10.2022 |
Illustris Pharmaceuticals, Inc.
Illustris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates bio-development company which delivers large molecules | Vorstandsvorsitzender | 01.01.2020 |
| REVANCE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 11.05.2017 |
| MEDICIS PHARMACEUTICAL CORP | Präsident | 11.12.2012 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 12 |
|---|---|
Medicis Pharmaceutical Corp.
Medicis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for dermatological usages | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Clarus Therapeutics, Inc.
Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for men hypogonadism | Health Technology |
Revance Therapeutics, Inc.
Revance Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for esthetics, skincare and therapeutics | Health Technology |
Pace University
Pace University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Financial Executives Institute | |
New York State Society of Certified Public Accountants
New York State Society of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Operates certified public accountant membership association | Commercial Services |
The Whispering Hope Ranch Foundation
The Whispering Hope Ranch Foundation Services to the Health IndustryHealth Services Provides therapeutic and recreational programs for children & youth facing adversity | Health Services |
Visions of Hope, Inc. | |
Verrica Pharmaceuticals, Inc.
Verrica Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Illustris Pharmaceuticals, Inc.
Illustris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates bio-development company which delivers large molecules | Health Technology |
Clarus Therapeutics Holdings, Inc.
Clarus Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops oral T-replacement therapies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen